{"transactions":[{"id":731634,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-18T20:31:03.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":30.57,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-26-000259","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071726000259/form4.xml","form_type":"4"}},{"id":945852,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:49:47.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":23372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 70,099 restricted stock units."}],"balance_after":70099,"source":{"system":"sec-edgar","filing":"0001698265-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000169826526000001/primarydocument.xml","form_type":"4"}},{"id":988410,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T19:37:01.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":46727,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares of common stock issuable on the vesting of restricted stock units (\"RSUs\"). The RSUs vest as to one-third of the total number of shares on each of November 20, 2026, November 20, 2027 and November 20, 2028, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":46727,"source":{"system":"sec-edgar","filing":"0001698265-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000169826525000004/primarydocument.xml","form_type":"4"}},{"id":1100793,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:56:12.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":21.78,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071725000263/form4.xml","form_type":"4"}},{"id":1496292,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T20:38:29.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":36.55,"expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-24-000277","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071724000277/form4.xml","form_type":"4"}},{"id":1860001,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:48:22.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":16200,"derivative":{"exercise_price":25.4,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001610717-23-000115","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000161071723000115/form4.xml","form_type":"4"}},{"id":2235302,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T22:22:03.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":12.29,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001567619-22-012694","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761922012694/doc1.xml","form_type":"4"}},{"id":2665457,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T21:03:27.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date."}],"balance_after":11000,"derivative":{"exercise_price":21.66,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001567619-21-012204","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761921012204/doc1.xml","form_type":"4"}},{"id":3096276,"issuer":{"id":4069,"kind":"organization","name":"IDEAYA Biosciences, Inc.","symbol":"IDYA"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-30T21:30:52.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from June 26, 2020 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":22000,"derivative":{"exercise_price":14.42,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001567619-20-012700","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1676725/000156761920012700/doc1.xml","form_type":"4"}},{"id":3312714,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"SVP Clinical Genomics Group"}}],"security":"Common Stock","published_at":"2020-01-13T21:36:40.000Z","date":"2020-01-09","kind":"tax_withholding","acquired":false,"shares":326,"price":334.6,"value":109079.6,"ownership":{"direct":true},"balance_after":6598,"source":{"system":"sec-edgar","filing":"0001127602-20-001466","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760220001466/form4.xml","form_type":"4"}},{"id":3377821,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"SVP Clinical Genomics Group"}}],"security":"Common Stock","published_at":"2019-11-07T21:35:05.000Z","date":"2019-11-05","kind":"tax_withholding","acquired":false,"shares":492,"price":300.87,"value":148028.04,"ownership":{"direct":true},"balance_after":6924,"source":{"system":"sec-edgar","filing":"0001127602-19-032191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760219032191/form4.xml","form_type":"4"}},{"id":3581820,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"SVP Clinical Genomics Group"}}],"security":"Common Stock","published_at":"2019-03-22T21:07:32.000Z","date":"2018-01-09","kind":"tax_withholding","acquired":false,"shares":358,"price":242.8,"value":86922.4,"ownership":{"direct":true},"balance_after":7416,"source":{"system":"sec-edgar","filing":"0001127602-19-012999","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760219012999/form4.xml","form_type":"4"}},{"id":3697527,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"SVP Clinical Genomics Group"}}],"security":"Common Stock","published_at":"2019-01-11T21:38:41.000Z","date":"2019-01-09","kind":"tax_withholding","acquired":false,"shares":327,"price":305.24,"value":99813.48,"ownership":{"direct":true},"balance_after":7774,"source":{"system":"sec-edgar","filing":"0001127602-19-001880","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760219001880/form4.xml","form_type":"4"}},{"id":3732793,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"EVP Clinical Genomics Group"}}],"security":"Performance Shares","published_at":"2018-12-13T23:21:26.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":5701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 2, 2022.  The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 2, 2022, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 2, 2022.  The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 2, 2022, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":5701,"derivative":{"expiration_date":"2022-01-02","underlying":"Common Stock","underlying_shares":5701},"source":{"system":"sec-edgar","filing":"0001127602-18-036231","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760218036231/form4.xml","form_type":"4"}},{"id":3732792,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"EVP Clinical Genomics Group"}}],"security":"Common Stock","published_at":"2018-12-13T23:21:26.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":1901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2019, November 5, 2020, November 5, 2021 and November 5, 2022, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":8101,"source":{"system":"sec-edgar","filing":"0001127602-18-036231","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760218036231/form4.xml","form_type":"4"}},{"id":3771682,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"EVP Clinical Genomics Group"}}],"security":"Common Stock","published_at":"2018-11-07T21:44:41.000Z","date":"2018-11-05","kind":"tax_withholding","acquired":false,"shares":253,"price":324.14,"value":82007.42,"ownership":{"direct":true},"balance_after":6200,"source":{"system":"sec-edgar","filing":"0001127602-18-032431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760218032431/form4.xml","form_type":"4"}},{"id":4133597,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"EVP Clinical Genomics Group"}}],"security":"Performance Shares","published_at":"2017-12-14T01:28:52.000Z","date":"2017-12-11","kind":"grant","acquired":true,"shares":8758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 3, 2021. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending January 3, 2021, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 3, 2021. The number of shares issued will range from 0% to 150% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending January 3, 2021, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."}],"balance_after":8758,"derivative":{"expiration_date":"2021-01-03","underlying":"Common Stock","underlying_shares":8758},"source":{"system":"sec-edgar","filing":"0001127602-17-034596","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760217034596/form4.xml","form_type":"4"}},{"id":4133596,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":36680,"kind":"person","name":"Hampton Malcolm Garret","position":1,"cik":"0001698265","reported_name":"Hampton Malcolm Garret","relationship":{"officer":true,"officer_title":"EVP Clinical Genomics Group"}}],"security":"Common Stock","published_at":"2017-12-14T01:28:52.000Z","date":"2017-12-11","kind":"grant","acquired":true,"shares":2920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2018, November 5, 2019, November 5, 2020, and November 5, 2021, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":6453,"source":{"system":"sec-edgar","filing":"0001127602-17-034596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760217034596/form4.xml","form_type":"4"}}]}